Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000605152 | SCV000722229 | likely benign | not specified | 2017-09-01 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000655216 | SCV000777142 | benign | Congenital hyperammonemia, type I | 2024-11-05 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV004711218 | SCV005258277 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Natera, |
RCV000655216 | SCV002076243 | likely benign | Congenital hyperammonemia, type I | 2019-12-16 | no assertion criteria provided | clinical testing | |
Prevention |
RCV003962777 | SCV004779901 | likely benign | CPS1-related disorder | 2019-08-15 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |